SGMO
Sangamo Therapeutics Inc

14,382
Mkt Cap
$148.06M
Volume
2.15M
52W High
$2.82
52W Low
$0.3846
PE Ratio
-1.00
SGMO Fundamentals
Price
$0.441
Prev Close
$0.44
Open
$0.443
50D MA
$0.5368
Beta
1.70
Avg. Volume
8.36M
EPS (Annual)
-$0.4856
P/B
22.74
Rev/Employee
$315,846.99
Loading...
Loading...
Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins. It focuses on three therapeutic areas: inherited metabolic diseases, central nervous system, and diseases and immunology, which consist of inflammatory and autoimmune diseases. It also offers complementary technology platforms such as gene therapy, ex vivo cell therapy, in vivo genome editing, and in vivo genome regulation. The company was founded by Edward O. Lanphier II in 1995 and is headquartered in Richmond, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
183

Frequently Asked Questions

What is Market Cap of Sangamo Therapeutics Inc?
What is the 52-week high for Sangamo Therapeutics Inc?
What is the 52-week low for Sangamo Therapeutics Inc?
What is Sangamo Therapeutics Inc stock price today?
What was Sangamo Therapeutics Inc stock price yesterday?
What is the PE ratio of Sangamo Therapeutics Inc?
What is the Price-to-Book ratio of Sangamo Therapeutics Inc?
What is the 50-day moving average of Sangamo Therapeutics Inc?
How many employess does Sangamo Therapeutics Inc has?

Latest SGMO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.